EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota-Derived Metabolites Mediate Immune Regulatory Networks in the Gut-Skin Axis of Psoriasis

Hengyan Zhang, Lijuan Zhu, Danping Li, Heguo Yan, Xuesong Yang, Ye Zhou

Frontiers in Bioscience-Landmark · 14.10.2026 · 31 (10)

DOI: 10.31083/fbl48099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 14.10.2026. Verfasst von Hengyan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zhaotong Hospital of Traditional Chinese Medicine/Zhaotong Hospital Affiliated with Yunnan University of Chinese Medicine,…. Hauptthemen laut MEDLINE: Psoriasis, Gastrointestinal Microbiome, Skin. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Department of Science and Technology Applied Basic Research Joint Special Project, Yunnan University of Chinese Medicine Joint University-Hospital Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic immune-mediated inflammatory disease affecting 2–3% people globally. Current biologic therapies targeting interleukin-23 and interleukin-17 pathways achieve only partial responses in most patients, highlighting the need for understanding upstream triggers. Emerging evidence implicates gut microbiome dysbiosis as a notable contributor to psoriasis pathogenesis through metabolite-mediated immune regulation. Psoriasis patients exhibit characteristic gut microbial alterations, including depletion of beneficial commensals such as Faecalibacterium prausnitzii and expansion of proinflammatory taxa. These compositional changes are associated with altered profiles of immunomodulatory metabolites, including short-chain fatty acids, tryptophan-derived indole compounds, and secondary bile acids, which promote regulatory T-cell differentiation, enhance immune tolerance through aryl hydrocarbon receptor activation, and modulate metabolic-immunological pathways. Such metabolic alterations may impair regulatory T cell function, promote T helper 17 (Th17) differentiation, compromise intestinal barrier integrity, and influence tissue-resident memory T cells that perpetuate disease chronicity. This process facilitates bacterial product translocation that amplifies inflammation, thereby amplifing relationship is bidirectional; psoriatic skin inflammation reciprocally affects gut homeostasis through circulating inflammatory mediators, systemic immune cell activation, and neuroendocrine stress pathways. Recent clinical evidence demonstrates that biologic therapies normalize gut microbiome composition and reduce trimethylamine N-oxide levels, supporting bidirectional gut-skin communication. These interactions create self-perpetuating cycles, suggesting that therapeutic strategies interrupting this feedback loop may offer novel treatment approaches. This review synthesizes current evidence on metabolite-mediated immune regulatory networks linking gut microbiome dysbiosis to psoriatic inflammation, evaluates clinical trials of microbiome-targeted interventions, and discusses methodological challenges, regulatory considerations, and future research directions for clinical translation. Understanding these mechanisms may inform the development of microbiome-targeted therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisGastrointestinal MicrobiomeSkinHumansDysbiosisAnimalsT-Lymphocytes, RegulatoryTh17 Cells

Stichwörter der Autor:innen

dysbiosisgastrointestinal microbiomeimmunomodulationpsoriasisshort-chain fatty acid

Autor:innen und Institutionen

  • Department of Dermatology, Zhaotong Hospital of Traditional Chinese Medicine/Zhaotong Hospital Affiliated with Yunnan University of Chinese Medicine, 657000 Zhaotong, Yunnan, China.
  • Department of Dermatology, Xinping Yi and Dai Autonomous County Traditional Chinese Medicine Hospital, 653400 Yuxi, Yunnan, China.
  • First Clinical Medical College, Yunnan University of Chinese Medicine, 650500 Kunming, Yunnan, China.
  • Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, 650500 Kunming, Yunnan, China.

Förderung

  • Yunnan Provincial Department of Science and Technology Applied Basic Research Joint Special Project
  • Yunnan University of Chinese Medicine Joint University-Hospital Fund

Zitieren

APA

Zhang, H., Zhu, L., Li, D., Yan, H., Yang, X., & Zhou, Y. (2026). Microbiota-Derived Metabolites Mediate Immune Regulatory Networks in the Gut-Skin Axis of Psoriasis. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl48099

Vancouver

Zhang H, Zhu L, Li D, Yan H, Yang X, Zhou Y. Microbiota-Derived Metabolites Mediate Immune Regulatory Networks in the Gut-Skin Axis of Psoriasis. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl48099

BibTeX
@article{Zhang2026,
  author = {Zhang, Hengyan and Zhu, Lijuan and Li, Danping and Yan, Heguo and Yang, Xuesong and Zhou, Ye},
  title = {Microbiota-Derived Metabolites Mediate Immune Regulatory Networks in the Gut-Skin Axis of Psoriasis},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {10},
  doi = {10.31083/fbl48099}
}
Kostenlos starten →